Most public-company M&A deals are challenged in court. Commonly referred to as merger objection litigation, these lawsuits typically involve a variety of claims brought by shareholders against the companies and their directors and officers involved in the transaction, including claims under Sections 14(a) and 10(b) of the Securities Exchange Act. Shareholders also assert breach of fiduciary duty claims against the directors and officers under state law.

Policyholders faced with these potential liabilities should be aware that their directors and officers (D&O) liability insurance companies may deny coverage based on the so-called “bump-up” or “inadequate consideration” exclusion (“the bump-up exclusion” or “the exclusion”). Insurance companies routinely and reflexively argue that the bump-up exclusion precludes coverage for any lawsuit following a corporate merger or similar transaction in which a settlement payment or judgment could be characterized as an increase (a “bump-up”) of the price paid for a target company.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]